| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/03/1997 | WO1997012050A1 Method for transferring genes to the heart using aav vectors |
| 04/03/1997 | WO1997012041A1 SHORT FORMS OF CHEMOKINE β-8 |
| 04/03/1997 | WO1997011940A1 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 04/03/1997 | WO1997011712A1 Ribosome fraction and composition containing same |
| 04/03/1997 | WO1997011711A1 Iron dextran formulations |
| 04/03/1997 | WO1997011693A1 Guanidino protease inhibitors |
| 04/03/1997 | WO1997011604A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/03/1997 | CA2233344A1 Guanidino protease inhibitors |
| 04/03/1997 | CA2233204A1 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 04/03/1997 | CA2233167A1 Method for transferring genes to the heart using aav vectors |
| 04/02/1997 | EP0765669A1 Pharmaceutical composition for the treatment of blood coagulation disorders, process to prepare it and its use |
| 04/02/1997 | EP0765667A1 Ribosomal fraction and composition containing it |
| 04/02/1997 | EP0765340A1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors |
| 04/02/1997 | EP0765339A1 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors |
| 04/02/1997 | EP0765337A1 The production of hemoglobin having a delta-like globin |
| 04/02/1997 | EP0765314A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 04/02/1997 | EP0765166A1 Radiolabeled annexin-galactose conjugates |
| 04/02/1997 | EP0765126A1 Therapeutic food composition and method to diminish blood sugar fluctuations |
| 04/02/1997 | EP0670735B1 Peripheralization of hematopoietic stem cells |
| 04/02/1997 | EP0655089A4 Effects of actin filaments on fibrin clot structure and lysis. |
| 04/02/1997 | EP0587625B1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof |
| 04/02/1997 | CN1146723A Thrombolytic enzyme and method of obtaining same |
| 04/01/1997 | US5616476 Synthetic isohirudins with improved stability |
| 04/01/1997 | US5616123 Delivery of solid drug compositions |
| 03/30/1997 | CA2186716A1 Hydroxypyridinones |
| 03/27/1997 | WO1997011053A1 Calcitriol derivatives and their uses |
| 03/26/1997 | EP0764659A1 Use of cyclodextrins and their derivatives for solubilising compounds of the Ginkgolide family |
| 03/26/1997 | CN1146157A Fibrin-specific antibody for use as an antithrombrotic agent |
| 03/26/1997 | CN1034335C Extraction and purification of an anticoagulant principle from the south american leech haementeria ghilanii |
| 03/25/1997 | US5614615 Sialyl Lewis X mimetics incorporating fucopeptides |
| 03/25/1997 | US5614537 Enzyme inhibitors of proline hydroxylase for inhibition of collagen biosynthesis and deposition |
| 03/25/1997 | US5614535 Adhesion receptor antagonists |
| 03/25/1997 | US5614531 Adhesion receptor antagonists |
| 03/25/1997 | US5614515 Preventing tissue adhesion after surgery |
| 03/25/1997 | US5614499 Anticoagulants; treatment or prophylaxis of thrombosis |
| 03/25/1997 | US5614493 Administering in a zymogen form |
| 03/25/1997 | US5613944 Plasma-like substance |
| 03/25/1997 | CA1339007C Collagen wound healing matrices and process for their production |
| 03/20/1997 | WO1997010265A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/20/1997 | WO1997010238A1 Quinolein-2(1h)-one derivatives as serotonin antagonists |
| 03/20/1997 | WO1997009996A1 Pharmaceutical combination preparations containing erythropoietin and iron preparations |
| 03/20/1997 | WO1997009972A1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 03/20/1997 | WO1996025498A3 Mpl ligand analogs |
| 03/20/1997 | DE19535571A1 Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten Pharmaceutical combination preparations and their use for the treatment of hemodialysis patients |
| 03/20/1997 | CA2232043A1 Nitrosated hemoglobins and therapeutic uses therefor |
| 03/19/1997 | EP0763596A1 Process for producing thrombin |
| 03/19/1997 | EP0763122A1 Retroviral gene therapy vectors and therapeutic methods based thereon |
| 03/19/1997 | EP0763120A1 Safe vectors for gene therapy |
| 03/19/1997 | EP0763061A1 Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments |
| 03/19/1997 | EP0763045A1 Haemopoietic maturation factor |
| 03/19/1997 | EP0763037A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763036A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0667770B1 Inhibition of tnf production |
| 03/19/1997 | EP0634998B1 Hydroxamic acid based collagenase and cytokine inhibitors |
| 03/19/1997 | EP0614360B1 Substituted beta-amino acid derivatives useful as platelet aggregation inhibitors |
| 03/19/1997 | CN1145618A New piperidine derivatives |
| 03/19/1997 | CN1145228A Medicine series for treatment of platelet decreasing purpura and anaemia |
| 03/18/1997 | US5612373 Certain diacyl hydrazine derivatives |
| 03/18/1997 | US5612369 Treatment of arterial and venous thrombotic occlusive disorders, inflammation, cancer, and neurodegenerative diseases |
| 03/18/1997 | US5612363 N,N-di(aryl) cyclic urea derivatives as anti-coagulants |
| 03/18/1997 | US5612359 Substituted biphenyl isoxazole sulfonamides |
| 03/18/1997 | US5612353 Anticoagulant |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/18/1997 | US5612335 Anticoagulants; combating/preventing diseases where cell aggregates occur or cell-matrix interactions play a part |
| 03/18/1997 | US5612334 Tricyclic benzazepine vasopressin antagonists |
| 03/18/1997 | US5612207 Red blood cell |
| 03/18/1997 | US5612206 Retrovirus infecting primate bone marrow cells and harvesting both non-adherent and adherent cells |
| 03/18/1997 | US5612029 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| 03/18/1997 | CA2008341C Benzocycloalcenyl dihydroxy alcanoic acid derivatives, process for their preparation and drugs containing the same |
| 03/13/1997 | WO1997008934A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/13/1997 | WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 03/13/1997 | WO1996040784A3 Method of solubilizing, purifying, and refolding protein |
| 03/13/1997 | WO1996040106A3 Methods for controlling highly unsaturated fatty acid content in various tissues |
| 03/13/1997 | CA2224874A1 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/12/1997 | EP0760858A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
| 03/12/1997 | EP0760818A1 Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0760812A1 Pharmaceutical diketopiperazine compounds |
| 03/12/1997 | EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists |
| 03/12/1997 | EP0565587B1 THE EFFECT OF N,N,N-TRIMETHYLSPHINGOSINE ON PROTEIN KINASE-C ACTIVITY; MELANOMA CELL GROWTH $i(IN VITRO); METASTATIC POTENTIAL $i(IN VIVO) AND HUMAN PLATELET AGGREGATION |
| 03/12/1997 | EP0489048B1 Inhibition of tumor growth by blockade of the protein c system |
| 03/12/1997 | EP0409940B1 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
| 03/12/1997 | CN1144656A Pharmaceutical compositions containing irbesartan |
| 03/11/1997 | US5610310 Cyclic lipid derivatives as potent PAF antagonists |
| 03/11/1997 | US5610308 Process for preparing intermediates for thrombin inhibitors |
| 03/11/1997 | US5610296 Chemical intermediates of antithrombotics |
| 03/11/1997 | US5610156 Tricyclic benzazepine vasopressin antagonists |
| 03/11/1997 | US5610147 Heating |
| 03/11/1997 | US5610141 Cell division stimulant |
| 03/11/1997 | US5610137 Transgenic, cross-linked hemoglobin |
| 03/06/1997 | WO1997008196A1 Neurturin and related growth factors |
| 03/06/1997 | WO1997008165A1 New cyclic guanidines, process for preparing the same and medicaments |
| 03/06/1997 | WO1997007791A1 Use of aminoadamantane compounds as immunoregulators |
| 03/06/1997 | CA2229903A1 New cyclic guanidines, process for preparing the same and medicaments |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759943A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 03/05/1997 | EP0759899A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
| 03/05/1997 | EP0759768A1 Vasoactive intestinal polypeptide |
| 03/05/1997 | EP0759767A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand |
| 03/05/1997 | EP0612349B1 Novel thrombin inhibitor protein from reduvii |
| 03/05/1997 | EP0586545B1 Electrophoretic display panel with tapered grid insulators and associated methods |